» Articles » PMID: 40012550

Editorial: Drug Repurposing for Cancer Treatment: Current and Future Directions

Overview
Journal Front Oncol
Specialty Oncology
Date 2025 Feb 27
PMID 40012550
Authors
Affiliations
Soon will be listed here.
References
1.
Muench J, Hamer A . Adverse effects of antipsychotic medications. Am Fam Physician. 2010; 81(5):617-22. View

2.
Karpel-Massler G, Kast R, Westhoff M, Dwucet A, Welscher N, Nonnenmacher L . Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect. J Neurooncol. 2014; 122(1):21-33. DOI: 10.1007/s11060-014-1688-7. View

3.
Shin S, Lee K, Choi Y, Lim H, Lee H, Lim Y . The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis. 2013; 34(9):2080-9. DOI: 10.1093/carcin/bgt169. View

4.
Yeh C, Wu A, Chang P, Chen K, Yang C, Yang S . Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med. 2012; 186(11):1180-8. DOI: 10.1164/rccm.201207-1180OC. View

5.
Kim H, Chong K, Ryu B, Park K, Yu M, Lee J . Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma. Cancers (Basel). 2019; 11(9). PMC: 6770574. DOI: 10.3390/cancers11091310. View